ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SHP Shire

4,690.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shire LSE:SHP London Ordinary Share JE00B2QKY057 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4,690.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Shire Share Discussion Threads

Showing 2951 to 2975 of 5350 messages
Chat Pages: Latest  130  129  128  127  126  125  124  123  122  121  120  119  Older
DateSubjectAuthorDiscuss
18/1/2018
13:03
PFE will come back for AGN imv.

SAN beginning to look interesting, another 4-5% lower might have a few.

essentialinvestor
18/1/2018
13:02
Support gone?
mbmiah
18/1/2018
12:29
Why is this still falling?

Because of revised revenue to 17-18bn?

Or some of the big guys like Pfizer not looking to buy?

superman21
18/1/2018
11:06
Quite apart from issues specific to Shire,the sector is suffering from to accelerating trend in the USA to cut health care costs by punitive action re drug costs.Hilary was bad but Trump might be worse,either way,there seems to be a consensus in the USA which could keep pharmas under a cloud.Shire's cheap but could well stay cheap in such an environment.Long term a buy.
steeplejack
18/1/2018
10:45
Bagged a few at 3421p, surprised to see it this low but buying into weakness at Shire has always worked out well in the past.

Does seem entirely sentiment driven and at some point fundamentals will force a restore to a fairer value. Is this big players punishing the board for not pushing ahead with a split in Q1?

If it follows a similar pattern as yesterday we can expect a revisit of the 3420p level later today so punter who missed the low this morning will likely get another chance I think.

Update - picked up more at 3417p

romeike
18/1/2018
10:33
Bought close to support 3420p, too good too miss at these levels, ex divi in March, put into the ISA
ny boy
18/1/2018
09:57
EI - you may well be correct given the continued fall this morning, though I still believe that the low share prices of certain pharma stocks at the moment represent a bargain opportunity for patient investors.

Now looking at two significant declines over two days on no news as part of a general decline since the start of the year with almost every day showing a drop.

romeike
18/1/2018
09:53
18th jan Liberum hold tp 4000p cut from 4100p
philanderer
18/1/2018
09:23
Rome, I tend to look at a valuation that includes net debt,
which is approx 50 Billion. FCF is the metric to focus on imv.

If current FCF can be maintained around these levels, Shire look cheap to me,
the market may be suggesting some doubt on that.

essentialinvestor
17/1/2018
18:31
Do you think Shire is maybe worth less than £30bn, if not they you are maybe buying at the bottom of a multi year trading range into a share that could quite reasonably increase 50% from its current position.
romeike
17/1/2018
16:50
Have to say was very tempted today but just could not bring myself to buy,
that's probably a bullish sign!.

essentialinvestor
17/1/2018
12:18
Juno Therapuetics up 50%, Celgene looking to buy
superman21
17/1/2018
12:04
superman , tend to agree , hopefully anyway :-)
philanderer
17/1/2018
10:16
Wasn't so sure about it dropping as far as 34.50 so bought a good chunk of shares at 34.92.
romeike
17/1/2018
10:13
Pfizer driving the price lower for buyout 🙂?
superman21
17/1/2018
09:51
Just made the target prices up from thin air I reckon
mbmiah
17/1/2018
09:33
Can't see anything justifying a valuation of Shire at just £31Bn, pretty ridiculous, I think Shire was what £25-£28Bn before it bought NPS + Baxalta?
romeike
17/1/2018
09:29
So who are the brokers giving the 'strong buys' , can't see them ?
philanderer
17/1/2018
09:09
TRY Hargraves, hl dot co dot uk
demo trader
17/1/2018
09:08
Can`t see any 'strong buys' ;-)

15th jan ShoreCap buy -
15th jan Liberum hold tp 4100p
11th jan Deutsche buy tp 5000p
10th jan JP Morgan overweight tp 5000p
9th jan Citigroup buy tp 5500p
2nd jan Piper Jaffray neutral tp $154
20th dec Jefferies buy tp 4900p
29th nov Soc Gen buy tp 8000p
24th nov Goldmans conviction buy tp 6000p
21st nov HSBC hold tp 3800p
6th nov Berenberg buy tp 6000p
1st nov Kepler buy tp 4600p
30th oct Credit Suisse outperform tp 4500p
30th oct Barclays equalweight tp 4000p
27th oct Cantor buy tp $222
27th oct Zacks hold -


27th oct ++++ Q3 results ++++

philanderer
17/1/2018
09:04
Out of 14 analysts

0 For Sell/strong Sell
3 Neutral
2 Buy
9 Strong buy


LOCK THEM UP :-) And release them if bid comes.

demo trader
17/1/2018
08:40
Awful drop to 3450 I'm afraid
mbmiah
17/1/2018
08:38
Oh dear , that quadruple bottom is not going to hold.

3400p anyone ?

philanderer
16/1/2018
22:28
Zak's opinion piece was written before the hot money exited on the 8th after the conference.

M&A may happen this year, but possibly not until H2 in my view when things become clearer re restructuring.

Maybe but who the hell knows.

Sp will likely be in the doldrums again until the next announcement, Feb 14, and to be honest any dramatic moves then are likely to be in the wrong direction.

Reading the above, you'd wonder why I'm still a holder :)

ruethewhirl
16/1/2018
16:32
No buyout rumour necessary, as Mir says, it could go back to £45 alone quite easily
romeike
Chat Pages: Latest  130  129  128  127  126  125  124  123  122  121  120  119  Older

Your Recent History

Delayed Upgrade Clock